Cargando…

Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer

Intravesical instillation of chemotherapeutic agents is a well-established treatment strategy to decrease recurrence following transurethral resection in non-muscle invasive bladder cancer. Gemcitabine is a recently developed treatment option. However, the curative effects of gemcitabine are far fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seo, Ho Kyung, Ahn, Kyung-Ohk, Jung, Nae-Rae, Shin, Ji-Sun, Park, Weon Seo, Lee, Kang Hyun, Lee, Sang-Jin, Jeong, Kyung-Chae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964210/ https://www.ncbi.nlm.nih.gov/pubmed/24504118

Ejemplares similares

The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression
por: Seo, Ho Kyung, et al.
Publicado: (2016)

Recommended oral sodium bicarbonate administration for urine alkalinization did not affect the concentration of mitomycin-C in non-muscle invasive bladder cancer patients
por: Seo, Ho Kyung, et al.
Publicado: (2017)

Precision on the ksi-s measurement
por: Le Diberder, F R
Publicado: (1991)

Observation of the decay Ksi^0_c --> Ksi- pi+ + c c in ALEPH
por: Bettarini, S, et al.
Publicado: (1994)

Pushing the limit of the ksi_s limit to the limit
por: Jaffe, D, et al.
Publicado: (1994)

Development of replication-competent adenovirus for bladder cancer by controlling adenovirus E1a and E4 gene expression with the survivin promoter
por: Seo, Ho Kyung, et al.
Publicado: (2014)

KSI-301: antibody biopolymer conjugate in retinal disorders
por: Chandrasekaran, Priya R., et al.
Publicado: (2021)

Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer
por: Kwon, Whi-An, et al.
Publicado: (2020)

Search for strange b baryons through Ksi +- lepton correlations
por: Boucrot, J, et al.
Publicado: (1993)

Electrostatic interaction of tumor-targeting adenoviruses with aminoclay acquires enhanced infectivity to tumor cells inside the bladder and has better cytotoxic activity
por: Kim, Soo-Yeon, et al.
Publicado: (2017)

Tau decays parameters: Measurement of the asymmetry parameter ksi in the electron channel
por: Adlung, A
Publicado: (1993)

A Surgically Treated Case of Ureterovesical Amyloidosis of the Bladder in a Patient with Idiopathic Thrombocytopenia
por: Kim, Sung Han, et al.
Publicado: (2018)

Single Institutional Experience of Bladder-Preserving Trimodality Treatment for Muscle-Invasive Bladder Cancer
por: Joung, Jae Young, et al.
Publicado: (2008)

Detection of Human Papillomavirus Infection and p16 Immunohistochemistry Expression in Bladder Cancer with Squamous Differentiation
por: Kim, Sung Han, et al.
Publicado: (2014)

Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database
por: Shin, Sangjin, et al.
Publicado: (2016)

RRM1 Expression as a Prognostic Biomarker for Unresectable or Recurrent Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin
por: Chun, Jung Won, et al.
Publicado: (2021)

Découverte simultanée aux USA et au CERN: "L'anti-ksi" est né
Publicado: (1962)

Effect of Tempering Temperature on Microstructure and Sulfide Stress Cracking of 125 Ksi Grade Casing Steel
por: Luo, Ming, et al.
Publicado: (2022)

Polymorphism and Fast Potassium‐Ion Conduction in the T5 Supertetrahedral Phosphidosilicate KSi(2)P(3)
por: Haffner, Arthur, et al.
Publicado: (2021)

Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder
por: Lee, Hye Won, et al.
Publicado: (2022)

Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells
por: Han, Na-Kyung, et al.
Publicado: (2016)

"L'Anti-Ksi", l'une des 30 "particules élémentaires" qui constituent la matière
Publicado: (1962)

Draft Genome Sequence of Trebouxiophyceae sp. Strain KSI-1, Isolated from an Island Hot Spring
por: Takahashi, Hiro, et al.
Publicado: (2018)

Effect of Oxide Metallurgy on Inclusions in 125 ksi Grade OCTG Steel with Sulfide Stress Corrosion Resistance
por: Zhang, Si, et al.
Publicado: (2022)

A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
por: Ahn, Hee Kyung, et al.
Publicado: (2014)

Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review
por: Cho, Min Hyun, et al.
Publicado: (2016)

Fibroblast Growth Factor Inhibitors for Treating Locally Advanced/Metastatic Bladder Urothelial Carcinomas via Dual Targeting of Tumor-Specific Oncogenic Signaling and the Tumor Immune Microenvironment
por: Lee, Hye Won, et al.
Publicado: (2021)

Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
por: Han, Sung Yong, et al.
Publicado: (2020)

Association Between Antibiotic Treatment and the Efficacy of Intravesical BCG Therapy in Patients With High-Risk Non-Muscle Invasive Bladder Cancer
por: Pak, Sahyun, et al.
Publicado: (2021)

XPS Investigation on Improving Hydrogen Sorption Kinetics of the KSiH(3) System by Using Zr-Based Catalysts
por: Tiwari, Anish, et al.
Publicado: (2022)

Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies
por: Kim, Kyung Hwan, et al.
Publicado: (2023)

DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study
por: Woo, Sang Myung, et al.
Publicado: (2017)

Congenital Chloride Diarrhea in Dizygotic Twins
por: Seo, Kyung Ah, et al.
Publicado: (2013)

Targeted Inhibition of O-Linked β-N-Acetylglucosamine Transferase as a Promising Therapeutic Strategy to Restore Chemosensitivity and Attenuate Aggressive Tumor Traits in Chemoresistant Urothelial Carcinoma of the Bladder
por: Lee, Hye Won, et al.
Publicado: (2022)

A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer
por: Woo, Sang Myung, et al.
Publicado: (2013)

Susceptibility of rat hippocampal neurons to hypothermia during development
por: Seo, Kyung Ah, et al.
Publicado: (2013)

P70S6K and Elf4E Dual Inhibition Is Essential to Control Bladder Tumor Growth and Progression in Orthotopic Mouse Non-muscle Invasive Bladder Tumor Model
por: Chi, Byung Hoon, et al.
Publicado: (2015)

Prostate stem cell antigen mRNA in blood is a predictor of survival after radical prostatectomy in patients with high-risk prostate cancer
por: Suh, Yoon Seok, et al.
Publicado: (2018)

Sunitinib Malate Synergistically Potentiates Anti-Tumor Effect of Gemcitabine in Human Bladder Cancer Cells
por: Yoon, Cheol Yong, et al.
Publicado: (2011)

Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy
por: Park, Inkeun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hnpnv54h886khc60vt21s4c6ka